The ABCD2 score is a 0–7 bedside estimate of very early stroke risk after TIA — age, blood pressure, clinical features, symptom duration, and diabetes — built for the emergency setting, not for home self-scoring. In the original validation, higher totals tracked higher 2-day stroke risk (about 1% at 0–3, 4% at 4–5, 8% at 6–7), and an ABCD2 of 4 or more remains part of how CHANCE and POINT defined high-risk TIA for short-course dual antiplatelet therapy.1,2,3 Later cohorts showed mixed discrimination, and strokes still occur in the “low-risk” band, so ABCD2 must not decide admission versus discharge on its own. Do not use the score to delay referral. It can inform selected clinical discussions of DAPT candidacy; every suspected TIA still needs prompt brain imaging, cervicocephalic vessel imaging, and heart-rhythm assessment. This page walks the components, the original risk bands, where the score fails, and where it still earns its keep — with a linked bedside calculator.

ABCD2 score at a glance

Add the points from the five components for a total of 0–7, then read the band. The percentages are the 2-day stroke risks from the original validation cohort.1 A score of 4 or more is the threshold CHANCE and POINT used as part of their high-risk definition.2,3

Component Criterion Points
A — Age60 years or older1
B — Blood pressureSystolic ≥ 140 or diastolic ≥ 90 mm Hg at presentation1
C — Clinical featuresUnilateral weakness
Speech disturbance without weakness
Neither
2
1
0
D — Duration≥ 60 minutes
10–59 minutes
Under 10 minutes
2
1
0
D — DiabetesPresent1
Total Band (original validation) 2-day stroke risk What it changes
0–3Low~1%Nothing about the workup: every suspected TIA still gets urgent brain, vessel, and rhythm evaluation
4–5Moderate~4%Meets the ABCD2 part of the CHANCE/POINT high-risk definition for short-course dual antiplatelet candidacy
6–7High~8%Same trial threshold as 4–5; urgent assessment remains necessary at every score

Need it scored? Use the ABCD2 score calculator. Want the mechanisms ABCD2 leaves out? See the Canadian TIA Score.

What the ABCD2 score measures

ABCD2 combines five clinical factors that, in the original work, predicted very early stroke risk after a TIA. Each is scored and the points are added for a total of 0 to 7.1

  • A — Age: 60 years or older = 1 point.
  • B — Blood pressure: systolic ≥ 140 mm Hg or diastolic ≥ 90 mm Hg at presentation = 1 point.
  • C — Clinical features: unilateral weakness = 2 points; speech disturbance without weakness = 1 point; neither = 0 points.
  • D — Duration: symptoms lasting ≥ 60 minutes = 2 points; 10–59 minutes = 1 point; under 10 minutes = 0 points.
  • D — Diabetes: present = 1 point.

The design is deliberately simple. Everything needed is available at the bedside within minutes — a history, a blood pressure cuff, and a quick neurologic exam — which is part of why the score spread so quickly into emergency departments and clinics.

The original risk groups

In the study that introduced and validated the unified score, higher totals tracked with higher short-term stroke risk. Patients were sorted into three bands, with the headline being the chance of a stroke within 2 days of the TIA.1

  • Low risk (0–3): roughly a 1 percent 2-day stroke risk.
  • Moderate risk (4–5): roughly a 4 percent 2-day stroke risk.
  • High risk (6–7): roughly an 8 percent 2-day stroke risk.

Read plainly, the message is that someone in the highest band had close to a 1-in-12 chance of stroke within just two days — a striking number that helped make the case for treating TIA as the medical urgency it is. The same pattern, with risk climbing as the score rose, held at 7 and 90 days as well.1

Why the score is not the whole story

The honest caveat is that ABCD2 has not performed as cleanly in later studies as it did in the paper that created it. Across independent cohorts, its ability to separate higher-risk from lower-risk patients has been inconsistent, and importantly, a meaningful number of strokes occur in people who score in the “low-risk” range. A reassuring score is not a guarantee of safety. The Canadian TIA Score includes additional clinical and test information. In a prospective Canadian cohort, it separated seven-day risk groups better than ABCD2; that finding does not make either score a substitute for diagnosis or vascular assessment. Perry et al., BMJ (2021).

For that reason, ABCD2 should not be used on its own to decide who gets admitted and who goes home. Some causes of TIA — a tight carotid narrowing, atrial fibrillation, a clot source in the heart — carry high stroke risk regardless of where the score lands. The factors the score leaves out can matter more than the ones it includes. Urgent evaluation — the full stroke workup after TIA — brain imaging, and assessment of the blood vessels (typically with imaging of the neck and head arteries) and the heart rhythm are what actually change outcomes, and they are warranted whether the score is 2 or 7.

Key point

Do not use ABCD2 to postpone referral or overrule clinical judgment. A low score never cancels the need for prompt vessel and heart-rhythm evaluation after a suspected TIA.

Worked example: a small total, an incomplete picture

Fictional teaching example, not a real patient: a 55-year-old adult has a blood pressure of 128/76 at assessment, no diabetes, and eight minutes of isolated speech disturbance without weakness.

ABCD2 componentPoints
Age below 600
BP below 140/900
Speech disturbance without weakness1
Duration below 10 minutes0
No diabetes0
Total1

The arithmetic answers only the scoring question. It does not establish the diagnosis, show the head and neck arteries, reveal an infarction, or exclude a heart-rhythm cause. Those missing facts can matter more than the total. The example must not be used as a discharge or medication rule. AHA: Top Things to Know (January 19, 2023).

Guideline context matters: NICE NG128 specifically advises against using ABCD2 to determine subsequent stroke risk or urgency of referral after suspected or confirmed TIA. A US emergency-department discussion of risk tools should not be presented as a universal referral rule. NICE NG128, recommendation 1.1.6 (2019; recommendation checked October 8, 2026).

For clinician education, compare the inputs in the ABCD2 calculator with the investigations the score cannot represent. Patients with possible stroke symptoms should call emergency services rather than use the calculator to decide whether to seek care.

Where the score still earns its keep

ABCD2 retains a practical role in selecting patients for short-course dual antiplatelet therapy — treatment with two clot-preventing medicines, usually aspirin plus clopidogrel, for a limited window. CHANCE and POINT enrolled patients with high-risk TIA (ABCD2 ≥4) or minor ischemic stroke (NIHSS ≤3), using separate entry criteria for the two groups. CHANCE used combined aspirin and clopidogrel for the first 21 days, followed by clopidogrel alone to day 90; POINT tested the combination for 90 days. Both reported fewer ischemic events with combination treatment, but the regimens and bleeding results differed.23

POINT found more major hemorrhage with dual therapy over 90 days. Bleeding can occur even during a short course; duration is only one factor in weighing benefit and harm.3 Current secondary-prevention guidance from the American Heart Association and American Stroke Association reflects this (see also the 2026 stroke guideline changes), recommending short-term dual antiplatelet therapy for selected high-risk TIA and minor stroke patients started early after the event.4 Here the score is doing what it does best — flagging a higher-risk group — rather than being asked to make a disposition decision on its own.

What to do if you think you have had a TIA

For patients and families, the single most important point is this: TIA symptoms that go away are still an emergency. Sudden weakness or numbness on one side, trouble speaking or understanding speech, a drooping face, vision loss, or a sudden severe loss of balance — even if it lasts only minutes — should prompt a call to emergency services (911 in the US) rather than a wait-and-see approach at home. The risk of a disabling stroke is highest in the first few days, exactly when evaluation and treatment can do the most good. Do not try to calculate your own ABCD2 score and talk yourself out of being seen; the score is a clinician's tool used alongside imaging and tests, not a home self-assessment.

This is clinician-oriented education, not an individual treatment or disposition recommendation. Do not start or combine medicines based on a score or this article.